303 related articles for article (PubMed ID: 21718690)
1. The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function.
Araud T; Graw S; Berger R; Lee M; Neveu E; Bertrand D; Leonard S
Biochem Pharmacol; 2011 Oct; 82(8):904-14. PubMed ID: 21718690
[TBL] [Abstract][Full Text] [Related]
2. A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization.
Hurst RS; Hajós M; Raggenbass M; Wall TM; Higdon NR; Lawson JA; Rutherford-Root KL; Berkenpas MB; Hoffmann WE; Piotrowski DW; Groppi VE; Allaman G; Ogier R; Bertrand S; Bertrand D; Arneric SP
J Neurosci; 2005 Apr; 25(17):4396-405. PubMed ID: 15858066
[TBL] [Abstract][Full Text] [Related]
3. An allosteric modulator of alpha7 nicotinic receptors, N-(5-Chloro-2,4-dimethoxyphenyl)-N'-(5-methyl-3-isoxazolyl)-urea (PNU-120596), causes conformational changes in the extracellular ligand binding domain similar to those caused by acetylcholine.
Barron SC; McLaughlin JT; See JA; Richards VL; Rosenberg RL
Mol Pharmacol; 2009 Aug; 76(2):253-63. PubMed ID: 19411608
[TBL] [Abstract][Full Text] [Related]
4. Function of partially duplicated human α77 nicotinic receptor subunit CHRFAM7A gene: potential implications for the cholinergic anti-inflammatory response.
de Lucas-Cerrillo AM; Maldifassi MC; Arnalich F; Renart J; Atienza G; Serantes R; Cruces J; Sánchez-Pacheco A; Andrés-Mateos E; Montiel C
J Biol Chem; 2011 Jan; 286(1):594-606. PubMed ID: 21047781
[TBL] [Abstract][Full Text] [Related]
5. PNU-120596, a positive allosteric modulator of mammalian α7 nicotinic acetylcholine receptor, is a negative modulator of ligand-gated chloride-selective channels of the gastropod Lymnaea stagnalis.
Vulfius CA; Lebedev DS; Kryukova EV; Kudryavtsev DS; Kolbaev SN; Utkin YN; Tsetlin VI
J Neurochem; 2020 Nov; 155(3):274-284. PubMed ID: 32248535
[TBL] [Abstract][Full Text] [Related]
6. Intrinsically low open probability of α7 nicotinic acetylcholine receptors can be overcome by positive allosteric modulation and serum factors leading to the generation of excitotoxic currents at physiological temperatures.
Williams DK; Peng C; Kimbrell MR; Papke RL
Mol Pharmacol; 2012 Oct; 82(4):746-59. PubMed ID: 22828799
[TBL] [Abstract][Full Text] [Related]
7. Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.
Grønlien JH; Håkerud M; Ween H; Thorin-Hagene K; Briggs CA; Gopalakrishnan M; Malysz J
Mol Pharmacol; 2007 Sep; 72(3):715-24. PubMed ID: 17565004
[TBL] [Abstract][Full Text] [Related]
8. The emergence of the uniquely human α7 nicotinic acetylcholine receptor gene and its roles in inflammation.
Peng W; Mao L; Dang X
Gene; 2022 Oct; 842():146777. PubMed ID: 35952843
[TBL] [Abstract][Full Text] [Related]
9. Positive modulation of alpha7 nAChR responses in rat hippocampal interneurons to full agonists and the alpha7-selective partial agonists, 4OH-GTS-21 and S 24795.
López-Hernández GY; Thinschmidt JS; Morain P; Trocme-Thibierge C; Kem WR; Soti F; Papke RL
Neuropharmacology; 2009 Mar; 56(4):821-30. PubMed ID: 19705574
[TBL] [Abstract][Full Text] [Related]
10. CHRNA7 and CHRFAM7A mRNAs: co-localized and their expression levels altered in the postmortem dorsolateral prefrontal cortex in major psychiatric disorders.
Kunii Y; Zhang W; Xu Q; Hyde TM; McFadden W; Shin JH; Deep-Soboslay A; Ye T; Li C; Kleinman JE; Wang KH; Lipska BK
Am J Psychiatry; 2015 Nov; 172(11):1122-30. PubMed ID: 26206074
[TBL] [Abstract][Full Text] [Related]
11. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
[TBL] [Abstract][Full Text] [Related]
12. Functional properties of alpha7 nicotinic acetylcholine receptors co-expressed with RIC-3 in a stable recombinant CHO-K1 cell line.
Roncarati R; Seredenina T; Jow B; Jow F; Papini S; Kramer A; Bothmann H; Dunlop J; Terstappen GC
Assay Drug Dev Technol; 2008 Apr; 6(2):181-93. PubMed ID: 18471073
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the molecular mechanism of the α7 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states.
Williams DK; Wang J; Papke RL
Mol Pharmacol; 2011 Dec; 80(6):1013-32. PubMed ID: 21885620
[TBL] [Abstract][Full Text] [Related]
14. A human-specific, truncated α7 nicotinic receptor subunit assembles with full-length α7 and forms functional receptors with different stoichiometries.
Lasala M; Corradi J; Bruzzone A; Esandi MDC; Bouzat C
J Biol Chem; 2018 Jul; 293(27):10707-10717. PubMed ID: 29784875
[TBL] [Abstract][Full Text] [Related]
15. A transcript coding for a partially duplicated form of α7 nicotinic acetylcholine receptor is absent from the CD4+ T-lymphocytes of patients with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).
Rozycka A; Dorszewska J; Steinborn B; Kempisty B; Lianeri M; Wisniewska K; Jagodzinski PP
Folia Neuropathol; 2013; 51(1):65-75. PubMed ID: 23553139
[TBL] [Abstract][Full Text] [Related]
16. The Human-Restricted Isoform of the α7 nAChR, CHRFAM7A: A Double-Edged Sword in Neurological and Inflammatory Disorders.
Di Lascio S; Fornasari D; Benfante R
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408823
[No Abstract] [Full Text] [Related]
17. Comparative pharmacology and computational modelling yield insights into allosteric modulation of human alpha7 nicotinic acetylcholine receptors.
Sattelle DB; Buckingham SD; Akamatsu M; Matsuda K; Pienaar IS; Jones AK; Sattelle BM; Almond A; Blundell CD
Biochem Pharmacol; 2009 Oct; 78(7):836-43. PubMed ID: 19549506
[TBL] [Abstract][Full Text] [Related]
18. The human-specific duplicated α7 gene inhibits the ancestral α7, negatively regulating nicotinic acetylcholine receptor-mediated transmitter release.
Martín-Sánchez C; Alés E; Balseiro-Gómez S; Atienza G; Arnalich F; Bordas A; Cedillo JL; Extremera M; Chávez-Reyes A; Montiel C
J Biol Chem; 2021; 296():100341. PubMed ID: 33515545
[TBL] [Abstract][Full Text] [Related]
19. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo.
Timmermann DB; Grønlien JH; Kohlhaas KL; Nielsen EØ; Dam E; Jørgensen TD; Ahring PK; Peters D; Holst D; Christensen JK; Malysz J; Briggs CA; Gopalakrishnan M; Olsen GM
J Pharmacol Exp Ther; 2007 Oct; 323(1):294-307. PubMed ID: 17625074
[TBL] [Abstract][Full Text] [Related]
20. Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors.
Innocent N; Livingstone PD; Hone A; Kimura A; Young T; Whiteaker P; McIntosh JM; Wonnacott S
J Pharmacol Exp Ther; 2008 Nov; 327(2):529-37. PubMed ID: 18664588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
